Nanotechnology-based ocular drug delivery systems: recent advances and future prospects

S Li, L Chen, Y Fu - Journal of Nanobiotechnology, 2023 - Springer
Ocular drug delivery has constantly challenged ophthalmologists and drug delivery
scientists due to various anatomical and physiological barriers. Static and dynamic ocular …

Genome editing in the treatment of ocular diseases

EH Choi, S Suh, AE Sears, R Hołubowicz… - … & molecular medicine, 2023 - nature.com
Genome-editing technologies have ushered in a new era in gene therapy, providing novel
therapeutic strategies for a wide range of diseases, including both genetic and nongenetic …

Characterization of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retina

S Kumar, YW Hsiao, VHY Wong, D Aubin… - Proceedings of the …, 2024 - pnas.org
CRISPR-Cas13 nucleases are programmable RNA-targeting effectors that can silence gene
expression in a transient manner. Recent iterations of Cas13 nucleases are compact for …

[HTML][HTML] Advanced gene therapy system for the treatment of solid tumour: A review

Y Ma, J Liao, H Cheng, Q Yang, H Yang - Materials Today Bio, 2024 - Elsevier
In contrast to conventional therapies that require repeated dosing, gene therapy can treat
diseases by correcting defective genes after a single transfection and achieving cascade …

[HTML][HTML] Adaptive optics imaging in inherited retinal diseases: A scoping review of the clinical literature

AC Britten-Jones, L Thai, JPM Flanagan… - Survey of …, 2024 - Elsevier
Adaptive optics (AO) imaging enables direct, objective assessments of retinal cells.
Applications of AO show great promise in advancing our understanding of the etiology of …

The opportunities and challenges of gene therapy for treatment of inherited forms of vision and hearing loss

EJ Simons, I Trapani - Human Gene Therapy, 2023 - liebertpub.com
Inherited forms of blindness and deafness are highly prevalent and severe conditions that
significantly impact the lives of millions of people worldwide. The lack of therapeutic options …

A pipeline for identifying guide RNA sequences that promote RNA editing of nonsense mutations that cause inherited retinal diseases

N Schneider, R Steinberg, A Ben-David… - … Therapy-Nucleic Acids, 2024 - cell.com
Adenosine deaminases acting on RNA (ADARs) are endogenous enzymes catalyzing the
deamination of adenosines to inosines, which are then read as guanosines during …

Programmable RNA editing with endogenous ADAR enzymes–a feasible option for the treatment of inherited retinal disease?

JS Bellingrath, ME McClements, MD Fischer… - Frontiers in Molecular …, 2023 - frontiersin.org
RNA editing holds great promise for the therapeutic correction of pathogenic, single
nucleotide variants (SNV) in the human transcriptome since it does not risk creating …

Syndromic Retinitis Pigmentosa

JS Karuntu, H Almushattat, AS Plomp… - Progress in Retinal and …, 2024 - Elsevier
Retinitis pigmentosa (RP) is a progressive inherited retinal dystrophy, characterized by the
degeneration of photoreceptors, presenting as a rod-cone dystrophy. Approximately 20-30 …

Decoding green food safety information dependency in the digital era: An intelligent validation using SEM-ANN framework

T Zhao, Q Shi, X Zhang, T Zhang - Journal of Retailing and Consumer …, 2024 - Elsevier
Dependence on mobile phone information in the Internet era is a crucial issue, and
psychological perception and personalized and accurate pushing significantly impact this …